Chad Kugler - Vascular Solutions Sr. VP of RandD

SVP

Mr. Chad Kugler is a Senior Vice President Research and Development of Vascular Solutions, Inc., since March 2014. Prior to joining the Company, he was the CoFounder, President and General Manager of BridgePoint Medical, a company that developed a proprietary, catheterbased system to treat coronary chronic total occlusions, from 2005 until its acquisition by Boston Scientific in 2012. From 2003 to 2005 Mr. Kugler was part of the founding team at Torax Medical, which developed a treatment for acid reflux disease. From 1997 to 2001 Mr. Kugler was the Director of Research and Development at Teramed, an aortic endovascular graft company acquired by Cordis in 2001. Mr. Kugler began his career as an engineer with SCIMEDBoston Scientific in 1992. since 2014.
Age 43
Tenure 10 years
Phone877 656-4251
Webwww.vasc.com

Vascular Solutions Management Efficiency

The company has return on total asset (ROA) of 0.13 % which means that it generated a profit of $0.13 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.15 %, meaning that it created $0.15 on every $100 dollars invested by stockholders. Vascular Solutions' management efficiency ratios could be used to measure how well Vascular Solutions manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 867 K in liabilities with Debt to Equity (D/E) ratio of 0.13, which may suggest the company is not taking enough advantage from borrowing. Vascular Solutions has a current ratio of 6.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Vascular Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Vascular Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vascular Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vascular to invest in growth at high rates of return. When we think about Vascular Solutions' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

SVP Age

Jeff HarrisWaste Management
62
David StewartAmeriprise Financial
64
Vascular Solutions, Inc., a medical device company, offer clinical solutions for treating coronary and peripheral vascular disease worldwide. Vascular Solutions (VASC) is traded on NASDAQ Exchange in USA and employs 568 people.

Management Performance

Vascular Solutions Leadership Team

Elected by the shareholders, the Vascular Solutions' board of directors comprises two types of representatives: Vascular Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vascular. The board's role is to monitor Vascular Solutions' management team and ensure that shareholders' interests are well served. Vascular Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vascular Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
John Erb, Independent Chairman of the Board
Brett Demchuk, Vice President - Product Quality
Phillip Nalbone, Vice President - Corporate Development
Brent Binkowski, Sr. VP of Operations
William Rutstein, Sr. VP of International Sales
Richard Kramp, Independent Director
Jorge Saucedo, Independent Director
Jonathan Hammond, Vice President - Manufacturing Engineering
Charmaine Sutton, Sr. VP of Operations
Chad Kugler, Sr. VP of RandD
Martin Emerson, Independent Director
Richard Nigon, Independent Director
James Hennen, CFO and Sr. VP of Fin.
Susan Christian, Vice President - Sales Operations
Paul OConnell, Independent Director
Carrie Powers, VP of Marketing
Howard Root, Co-Founder, CEO and Director

Vascular Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vascular Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vascular Solutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vascular Solutions' short interest history, or implied volatility extrapolated from Vascular Solutions options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Vascular Stock

If you are still planning to invest in Vascular Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Solutions' history and understand the potential risks before investing.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments